AA
48
-12
GOOG
50
-3
MSFT
50
3
WU
32
2
CMA
61
5
AMG
54
2
RHI
59
2
SO
53
-4
DRI
53
5
PEP
48
6
EQIX
64
2
TGT
22
2
DD
63
3
DG
6
2
WFC
79
4
ZION
65
2
PSA
58
2
ORCL
65
-2
CCI
31
3
NWL
53
3
AA
48
-12
GOOG
50
-3
MSFT
50
3
WU
32
2
CMA
61
5
AMG
54
2
RHI
59
2
SO
53
-4
DRI
53
5
PEP
48
6
EQIX
64
2
TGT
22
2
DD
63
3
DG
6
2
WFC
79
4
ZION
65
2
PSA
58
2
ORCL
65
-2
CCI
31
3
NWL
53
3
Financhill
Back

Akari Therapeutics PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
10

AKTX
Akari Therapeutics PLC

Last Price:
1.30
Seasonality Move:
-10.36%
Sell
22

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.66
Seasonality Move:
53.66%
Sell
10
Akari Therapeutics PLC (AKTX) is a Sell

Is Akari Therapeutics PLC a Buy, Sell or Hold?

  • The current Akari Therapeutics PLC [AKTX] share price is $1.30. The Score for AKTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • AKTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
22
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.66. The Score for ADAP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKTX Stock Price Chart

What is Akari Therapeutics PLC's stock price today?

  • The Akari Therapeutics PLC share price today is $1.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 26.66 Sell
Chaikin Money Flow: 110616 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.81 - 2.57) Sell
Bollinger Bands (100): (2.43 - 3.73) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 39.76 Sell
Chaikin Money Flow: 1207506 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.66 - 0.82) Sell
Bollinger Bands (100): (0.8 - 1.2) Sell

AKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.8 Sell
20-day SMA: 2.18 Sell
50-day SMA: 2.57 Sell
200-day SMA: 2.53 Sell
8-day EMA: 1.7 Sell
20-day EMA: 2.05 Sell
50-day EMA: 2.47 Sell
200-day EMA: 2.91 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.65 Buy
20-day SMA: 0.73 Sell
50-day SMA: 0.84 Sell
200-day SMA: 1.11 Sell
8-day EMA: 0.67 Sell
20-day EMA: 0.72 Sell
50-day EMA: 0.83 Sell
200-day EMA: 0.99 Sell

Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.

Akari Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):